📖

GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PD

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-experiments-glp1-responder-predicti

Related Entities

experiments-glp1-responder-prediction-pd

Metadata

slug	experiments-glp1-responder-prediction-pd
entity_type	experiment
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (71)

derives_from🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin95%

mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr80%

mentions🔬How does metabolic reprogramming (glucose metabolism shifts,75%

mentions🧫Tirzepatide vs Semaglutide Anti-Atherosclerotic Effects in A70%

mentions🧫AAV-LRRK2 IND-Enabling Study Design70%

mentions🧫Combination Therapy Sequencing in Parkinson's Disease70%

mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD70%

mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%

mentions🧫Cytochrome Therapeutics70%

mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design70%

related🧫Cytochrome Therapeutics70%

see_also📖CNTNAP4 Gene60%

see_also📖Age-Sensitive Cortical Vulnerability in Parkinson's Dis60%

see_also📖entities-gba160%

see_also📖LRRK2 G2019S Transgenic Mouse Model60%

see_also📖DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

see_also📖APOB Gene60%

see_also📖DOT1L Gene60%

see_also📖eef1a160%

see_also📖IDH1 Gene - Isocitrate Dehydrogenase 160%

see_also📖MCL1 Gene - Myeloid Cell Leukemia 160%

mentions🧪Smartphone-Detected Motor Variability Correction55%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade55%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation55%

mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%

mentions🧪Microbial Inflammasome Priming Prevention50%

mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice50%

mentions🧫TLR expression in α-synuclein overexpressing mice50%

mentions🧫Dexamethasone treatment study in α-synuclein mice50%

mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪APOE-TREM2 Interaction Modulation50%

mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%

mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model44%

mentions🧫Leukocyte gene expression analysis in COVID-19 patients44%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise44%

mentions🧫Nrf2 inhibitor ML385 mechanism validation experiment44%

mentions🧫Acteoside treatment in LPS-induced SALI mouse model44%

mentions🧫Acteoside effects on RAW264.7 macrophage cells44%

mentions🧫Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr44%

mentions🧫Functional analysis of EFNB1-EPHB4 interaction in EMT44%

mentions🧫Spatial transcriptomic analysis of multistage ESCC developme44%